Gyon Technologies Capital Management, LP Amgen Inc Transaction History

Gyon Technologies Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $436,964 - $486,265	-1,894 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $415,297 - $459,427	1,894 New	1,894 $458,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $322,340 - $357,613	-1,380 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $17,752 - $20,688	80 Added 6.15%	1,380 $343,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $281,294 - $334,971	1,300 New	1,300 $299,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.